The belated US FDA approval of the adenosine A2A receptor antagonist istradefylline for treatment of Parkinson's disease

JF Chen, RA Cunha - Purinergic signalling, 2020 - Springer
After more than two decades of preclinical and clinical studies, on August 27, 2019, the US
Food and Drug Administration (FDA) approved the adenosine A 2A receptor antagonist …

[HTML][HTML] Nucleotide-and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade

GG Yegutkin - Biochimica et Biophysica Acta (BBA)-Molecular Cell …, 2008 - Elsevier
The involvement of extracellular nucleotides and adenosine in an array of cell-specific
responses has long been known and appreciated, but the integrative view of purinergic …

Trans-ethnic association study of blood pressure determinants in over 750,000 individuals

A Giri, JN Hellwege, JM Keaton, J Park, C Qiu… - Nature …, 2019 - nature.com
In this trans-ethnic multi-omic study, we reinterpret the genetic architecture of blood pressure
to identify genes, tissues, phenomes and medication contexts of blood pressure …

A database of tissue-specific rhythmically expressed human genes has potential applications in circadian medicine

MD Ruben, G Wu, DF Smith, RE Schmidt… - Science translational …, 2018 - science.org
The discovery that half of the mammalian protein-coding genome is regulated by the
circadian clock has clear implications for medicine. Recent studies demonstrated that the …

Dosing time matters

MD Ruben, DF Smith, GA FitzGerald, JB Hogenesch - Science, 2019 - science.org
Physicians diagnose and administer treatment as needed; time of day is rarely considered.
Yet, accumulating evidence shows that our molecular clocks orchestrate 24-hour circadian …

Caffeine and exercise

TE Graham - Sports medicine, 2001 - Springer
Caffeine is a common substance in the diets of most athletes and it is now appearing in
many new products, including energy drinks, sport gels, alcoholic beverages and diet aids. It …

Focusing on adenosine receptors as a potential targeted therapy in human diseases

WI Effendi, T Nagano, K Kobayashi, Y Nishimura - Cells, 2020 - mdpi.com
Adenosine is involved in a range of physiological and pathological effects through
membrane-bound receptors linked to G proteins. There are four subtypes of adenosine …

Adenosine: physiology, pharmacology, and clinical applications

J Layland, D Carrick, M Lee, K Oldroyd… - JACC: Cardiovascular …, 2014 - jacc.org
Adenosine is a ubiquitous extracellular signaling molecule with essential functions in human
physiology. Due to the widespread expression of adenosine receptors, it has far-reaching …

Ticagrelor increases adenosine plasma concentration in patients with an acute coronary syndrome

L Bonello, M Laine, N Kipson, J Mancini, O Helal… - Journal of the American …, 2014 - jacc.org
Objectives: This study aimed to investigate the impact of ticagrelor on adenosine plasma
concentration (APC) in acute coronary syndrome (ACS) patients. Background: Ticagrelor is …

The equilibrative nucleoside transporter family, SLC29

SA Baldwin, PR Beal, SYM Yao, AE King, CE Cass… - Pflügers Archiv, 2004 - Springer
The human SLC29 family of proteins contains four members, designated equilibrative
nucleoside transporters (ENTs) because of the properties of the first-characterised family …